{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:52:31Z","timestamp":1776217951164,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V112C-228"],"award-info":[{"award-number":["V112C-228"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.heliyon.2023.e14456","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T16:45:01Z","timestamp":1678553101000},"page":"e14456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the timing of using direct oral anticoagulants after ischemic stroke for patients with atrial fibrillation"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2792-1825","authenticated-orcid":false,"given":"Hui-Tzu","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2489-0055","authenticated-orcid":false,"given":"Kuan-Hsuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5965-096X","authenticated-orcid":false,"given":"Chun-Jen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5218-716X","authenticated-orcid":false,"given":"Chia-Chen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuh-Lih","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e14456_bib1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(13)70055-3","article-title":"Factors influencing haemorrhagic transformation in ischaemic stroke","volume":"12","author":"\u00c1lvarez-Sab\u00edn","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2023.e14456_bib2","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/01.STR.14.5.688","article-title":"Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study","volume":"14","author":"Hart","year":"1983","journal-title":"Stroke"},{"key":"10.1016\/j.heliyon.2023.e14456_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010133","article-title":"Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: time to initiation of oral anticoagulant therapy and outcomes","volume":"7","author":"Paciaroni","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.heliyon.2023.e14456_bib4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","article-title":"Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation","volume":"50","author":"Shen","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e14456_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4070\/kcj.2018.0190","article-title":"Stroke prevention in atrial fibrillation: focus on Asian patients","volume":"48","author":"Li","year":"2018","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.heliyon.2023.e14456_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e14456_bib7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e14456_bib8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e14456_bib9","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e14456_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ana.25489","article-title":"Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation","volume":"85","author":"Seiffge","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.heliyon.2023.e14456_bib11","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1212\/WNL.0000000000003283","article-title":"Early start of DOAC after ischemic stroke: risk of intracranial hemorrhage and recurrent events","volume":"87","author":"Seiffge","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2023.e14456_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007034","article-title":"Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with non\u2013vitamin\u2010K oral anticoagulants (RAF\u2010NOACs) study","volume":"6","author":"Paciaroni","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.heliyon.2023.e14456_bib13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jnnp-2018-318890","article-title":"Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study","volume":"90","author":"Wilson","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.heliyon.2023.e14456_bib14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/STROKEAHA.119.028118","article-title":"Early initiation of direct oral anticoagulants after onset of stroke and short- and long-term outcomes of patients with nonvalvular atrial fibrillation","volume":"51","author":"Mizoguchi","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.heliyon.2023.e14456_bib15","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.heliyon.2023.e14456_bib16","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.heliyon.2023.e14456_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.heliyon.2023.e14456_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jfma.2013.09.009","article-title":"Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database","volume":"114","author":"Hsieh","year":"2015","journal-title":"J. Formos. Med. Assoc."},{"issue":"Suppl. 1","key":"10.1016\/j.heliyon.2023.e14456_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/pds.2312","article-title":"A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data","volume":"21","author":"Andrade","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.heliyon.2023.e14456_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2016.04.069","article-title":"Validation of algorithms to identify stroke risk factors in patients with acute ischemic stroke, transient ischemic attack, or intracerebral hemorrhage in an administrative claims database","volume":"215","author":"Sung","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e14456_bib21","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jacc.2014.06.1203","article-title":"Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial fibrillation","volume":"64","author":"Chao","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e14456_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application","volume":"2","author":"Lund","year":"2015","journal-title":"Curr. Epidemiol. Rep."},{"key":"10.1016\/j.heliyon.2023.e14456_bib23","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1161\/STROKEAHA.107.510321","article-title":"Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome","volume":"39","author":"Paciaroni","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.heliyon.2023.e14456_bib24","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.heliyon.2023.e14456_bib25","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.heliyon.2023.e14456_bib26","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Subcommittee on Control of Anticoagulation, Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.heliyon.2023.e14456_bib27","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.mlr.0000160417.39497.a9","article-title":"Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors","volume":"43","author":"Birman-Deych","year":"2005","journal-title":"Med. Care"},{"key":"10.1016\/j.heliyon.2023.e14456_bib28","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1160\/TH16-05-0400","article-title":"Usefulness of Health Registers for detection of bleeding events in outcome studies","volume":"116","author":"Friberg","year":"2016","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.heliyon.2023.e14456_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.005969","article-title":"Real-world Adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"13","author":"Ozaki","year":"2020","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.heliyon.2023.e14456_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.heliyon.2023.e14456_bib31","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.heliyon.2023.e14456_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pds.2087","article-title":"Validation of the national health insurance research database with ischemic stroke cases in Taiwan","volume":"20","author":"Cheng","year":"2011","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.heliyon.2023.e14456_bib33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.0006-341X.2001.00114.x","article-title":"A solution to the problem of monotone likelihood in Cox regression","volume":"57","author":"Heinze","year":"2001","journal-title":"Biometrics"},{"key":"10.1016\/j.heliyon.2023.e14456_bib34","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/STROKEAHA.115.008891","article-title":"Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study","volume":"46","author":"Paciaroni","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.heliyon.2023.e14456_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037234","article-title":"Dabigatran initiation in patients with non-valvular AF and first acute ischaemic stroke: a retrospective observational study from the SITS registry","volume":"10","author":"Escudero-Martinez","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.heliyon.2023.e14456_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105169","article-title":"Anticoagulation choice and timing in stroke due to atrial fibrillation: a survey of US stroke specialists (ACT-SAFe)","volume":"29","author":"Rybinnik","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.heliyon.2023.e14456_bib37","doi-asserted-by":"crossref","first-page":"c3920","DOI":"10.1136\/bmj.c3920","article-title":"Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review","volume":"341","author":"Cordoba","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2023.e14456_bib38","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ana.25844","article-title":"Anticoagulation timing in Cardioembolic stroke and recurrent event risk","volume":"88","author":"Yaghi","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.heliyon.2023.e14456_bib39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bimj.201700067","article-title":"Variable selection - a review and recommendations for the practicing statistician","volume":"60","author":"Heinze","year":"2018","journal-title":"Biom. J."},{"key":"10.1016\/j.heliyon.2023.e14456_bib40","doi-asserted-by":"crossref","first-page":"f11","DOI":"10.1093\/ehjcvp\/pvab002","article-title":"Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 605 771 patients","volume":"7","author":"Menichelli","year":"2021","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.heliyon.2023.e14456_bib41","article-title":"Real-world oral anticoagulants for Asian patients with non-valvular atrial fibrillation: a PRISMA-compliant article","volume":"100","author":"Kim","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.heliyon.2023.e14456_bib42","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.heliyon.2023.e14456_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212354","article-title":"Rivaroxaban administration after acute ischemic stroke: the RELAXED study","volume":"14","author":"Yasaka","year":"2019","journal-title":"PLoS One"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023016638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023016638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:56:30Z","timestamp":1776214590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023016638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2405844023016638"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14456","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the timing of using direct oral anticoagulants after ischemic stroke for patients with atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e14456"}}